Cargando…

Cripto-1 in TNBC

Detalles Bibliográficos
Autores principales:	Castro, Nadia P, Salomon, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586090/ https://www.ncbi.nlm.nih.gov/pubmed/26298547

Ejemplares similares

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

TNBC invasion: downstream of STAT3
por: Jackson, James G., et al.
Publicado: (2017)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
por: Francescangeli, F, et al.
Publicado: (2015)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas
por: Kuniyasu, Hiroki, et al.
Publicado: (1991)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
por: Bandeira, Carla Letícia, et al.
Publicado: (2014)

Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi
por: Strizzi, Luigi, et al.
Publicado: (2016)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
por: Arboretto, Paola, et al.
Publicado: (2021)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma()
por: Ye, Qing, et al.
Publicado: (2019)

CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2015)

Chemotherapy with ceramide in TNBC
por: Legembre, Patrick, et al.
Publicado: (2015)

GHRH-antagonists in TNBC
por: Engel, Jörg B.
Publicado: (2015)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
por: Qi, C. F., et al.
Publicado: (1994)

Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities
por: Terry, Stéphane, et al.
Publicado: (2019)

High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection
por: Zhang, Yingyu, et al.
Publicado: (2018)

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
por: Ishii, Hiroko, et al.
Publicado: (2021)

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2022)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC
por: Tan, Renbo, et al.
Publicado: (2020)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
por: Xue, Yi-Jun, et al.
Publicado: (2019)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells
por: Arnouk, Hilal, et al.
Publicado: (2021)

Cripto Is Targeted by miR-1a-3p in a Mouse Model of Heart Development
por: Angrisano, Tiziana, et al.
Publicado: (2023)

The Evaluation of Cytotoxic Properties from CCB-2 Sugar Complexes Against TNBC and Non-TNBC Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2021)

Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
por: Prezioso, Carolina, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0tt63p983rtra3942o3qppqnt3